Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert reviewASCIERTO, Paolo A; GOGAS, Helen J; JACQUES GROB, Jean et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 149-161, issn 1040-8428, 13 p.Article

Brain metastases from gastrointestinal tumours: Tailoring the approach to maximize the outcomeMENIS, Jessica; FONTANELLA, Caterina; FOLLADOR, Alessandro et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 1, pp 32-44, issn 1040-8428, 13 p.Article

Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current evidenceNUMICO, Gianmauro; FRANCO, Pierfrancesco; RICARDI, Umberto et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 112-120, issn 1040-8428, 9 p.Article

Issues to be considered when studying cancer in vitroCUNDERLIKOVA, Beata.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 95-111, issn 1040-8428, 17 p.Article

Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factorsCLARKE, Stephen J; KARAPETIS, Christos S; GIBBS, Peter et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 121-135, issn 1040-8428, 15 p.Article

Comorbidity and survival after early breast cancer. A reviewHOLM LAND, Lotte; OKSBJERG DALTON, Susanne; LEMBRECHT JØRGENSEN, Trine et al.Critical reviews in oncology/hematology. 2012, Vol 81, Num 2, pp 196-205, issn 1040-8428, 10 p.Article

Defining and predicting indolent and low risk prostate cancerBANGMA, Chris H; ROOBOL, Monique J.Critical reviews in oncology/hematology. 2012, Vol 83, Num 2, pp 235-241, issn 1040-8428, 7 p.Article

Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatmentMARESCH, Judith; SCHOPPMANN, Sebastian F; THALLINGER, Christiane M. R et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 3, pp 310-322, issn 1040-8428, 13 p.Article

Life-expectancy of patients enrolled in phase 1 clinical trials: A systematic review of published prognostic modelsPLOQUIN, Anne; OLMOS, David; FERTE, Charles et al.Critical reviews in oncology/hematology. 2012, Vol 83, Num 2, pp 242-248, issn 1040-8428, 7 p.Article

Management of unfavourable carcinoma of unknown primary site: Synthesis of recent literatureYAOVI AMELA, Eric; LAURIDANT-PHILIPPIN, Géraldine; COUSIN, Sophie et al.Critical reviews in oncology/hematology. 2012, Vol 84, Num 2, pp 213-223, issn 1040-8428, 11 p.Article

Necroptosis: An emerging form of programmed cell deathWEI WU; PENG LIU; JIANYONG LI et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 3, pp 249-258, issn 1040-8428, 10 p.Article

Octreotide for malignant bowel obstruction: Twenty years afterMERCADANTE, Sebastiano; PORZIO, Giampiero.Critical reviews in oncology/hematology. 2012, Vol 83, Num 3, pp 388-392, issn 1040-8428, 5 p.Article

Polycomb genes and cancer: Time for clinical application?CREA, Francesco; PAOLICCHI, Elisa; MARQUEZ, Victor E et al.Critical reviews in oncology/hematology. 2012, Vol 83, Num 2, pp 184-193, issn 1040-8428, 10 p.Article

Target therapy in elderly breast cancer patientsCARLI, Paolo; TURCHET, Elisa; CRIVELLARI, Diana et al.Critical reviews in oncology/hematology. 2012, Vol 83, Num 3, pp 422-431, issn 1040-8428, 10 p.Article

Targeting insulin-like growth factor in breast cancer therapeuticsKARAMOUZIS, Michalis V; PAPAVASSILIOU, Athanasios G.Critical reviews in oncology/hematology. 2012, Vol 84, Num 1, pp 8-17, issn 1040-8428, 10 p.Article

Therapeutic and prognostic importance of epithelial―mesenchymal transition in liver cancers: Insights from experimental modelsOGUNWOBI, Olorunseun O; CHEN LIU.Critical reviews in oncology/hematology. 2012, Vol 83, Num 3, pp 319-328, issn 1040-8428, 10 p.Article

Turning promise into progress for antiangiogenic agents in epithelial ovarian cancerVAN DER BILT, Arne R. M; DE VRIES, Elisabeth G. E; DE JONG, Steven et al.Critical reviews in oncology/hematology. 2012, Vol 84, Num 2, pp 224-242, issn 1040-8428, 19 p.Article

Primary plasma cell leukemia in the era of new drugs: Has something changed?MUSTO, Pellegrino; PAGANO, Livio; OMEDE, Paola et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 2, pp 141-149, issn 1040-8428, 9 p.Article

Tailored imaging of islet cell tumors of the pancreas amidst increasing optionsFIEBRICH, Helle-Brit; ASSELT, Sophie J. Van; BROUWERS, Adrienne H et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 2, pp 213-226, issn 1040-8428, 14 p.Article

Childhood medulloblastomaMASSIMINO, Maura; GIANGASPERO, Felice; LUISA GARRE, Maria et al.Critical reviews in oncology/hematology. 2011, Vol 79, Num 1, pp 65-83, issn 1040-8428, 19 p.Article

Enteropathy-associated T-cell lymphomaFERRERI, Andres J. M; LUIGI ZINZANI, Pier; GOVI, Silvia et al.Critical reviews in oncology/hematology. 2011, Vol 79, Num 1, pp 84-90, issn 1040-8428, 7 p.Article

First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)SASTRE, J; ARANDA, E; HIDALGO, M et al.Critical reviews in oncology/hematology. 2011, Vol 77, Num 1, pp 79-85, issn 1040-8428, 7 p.Article

Intrathecal chemotherapy in lymphomatous meningitisCANOVA, Fabio; MARINO, Dario; TRENTIN, Chiara et al.Critical reviews in oncology/hematology. 2011, Vol 79, Num 2, pp 127-134, issn 1040-8428, 8 p.Article

Positron emission tomography and colorectal cancerLIN, Michael; KAREN WONG; WENG LEONG NG et al.Critical reviews in oncology/hematology. 2011, Vol 77, Num 1, pp 31-48, issn 1040-8428, 18 p.Article

The significance of early, major and stable molecular responses in chronic myeloid leukemia in the imatinib eraBRECCIA, Massimo; ALIMENA, Giuliana.Critical reviews in oncology/hematology. 2011, Vol 79, Num 2, pp 135-143, issn 1040-8428, 9 p.Article